OU Health Acquires Dean McGee Eye Institute

Published on January 7, 2026
NORMAN, Okla.—OU Health, Oklahoma’s flagship academic health system, announced it has acquired the Dean McGee Eye Institute (DMEI), a nationally recognized freestanding eye institute. The acquisition, finalized on January 1, 2026, will create the OU Health Dean McGee Eye Institute, strengthen a long-standing relationship, advance DMEI’s role in the academic health mission and honor its legacy in eyecare, research and education, the announcement said. Leaders from OU Health, DMEI and the University of Oklahoma spent several months discussing and planning the integration.
Continue reading on website
Other news

Studies Suggest GLP-1 Drug Use Linked to Lowered AMD Risk

January 7, 2026
Both of these studies found that GLP-1 therapy lowered dry AMD risk compared to outcomes of patients using other diabetes medications. Photo: Tanuj P. Banker, MD. Click image to enlarge. Given the increased use of glucagon-like peptide-1 (GLP-1) receptor agonist (RA) drugs over the past few years, there remains a need to establish whether this therapy is associated with age-

Bausch + Lomb Completes Refinancing of Outstanding Term B Loans

January 7, 2026
VAUGHAN, Ontario—Global eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO) announced that it has closed a previously announced credit agreement refinancing, entering into a fourth amendment to its credit agreement providing for a $2.8 billion ($2,802,125,000) tranche of new term B loans (replacement term loans), the proceeds of which were used to refinance all of its outstanding term B